A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT06747351 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Interventions

BIOLOGICAL: TAK-881
BIOLOGICAL: HYQVIA
DEVICE: SC Investigational Needle Sets

Sponsor

Takeda

Collaborators

[object Object]